A detailed history of Petrus Trust Company, Lta transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Petrus Trust Company, Lta holds 23,373 shares of FLGT stock, worth $454,371. This represents 0.05% of its overall portfolio holdings.

Number of Shares
23,373
Previous 21,751 7.46%
Holding current value
$454,371
Previous $426,000 19.01%
% of portfolio
0.05%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$19.6 - $25.06 $31,791 - $40,647
1,622 Added 7.46%
23,373 $507,000
Q1 2024

May 15, 2024

SELL
$21.55 - $29.29 $58,185 - $79,083
-2,700 Reduced 11.04%
21,751 $471,000
Q4 2023

Feb 14, 2024

BUY
$23.64 - $30.27 $166,732 - $213,494
7,053 Added 40.54%
24,451 $706,000
Q3 2023

Nov 14, 2023

BUY
$26.74 - $40.81 $465,222 - $710,012
17,398 New
17,398 $465,000
Q4 2022

Feb 14, 2023

BUY
$29.23 - $40.28 $210,806 - $290,499
7,212 New
7,212 $214,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $588M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Petrus Trust Company, Lta Portfolio

Follow Petrus Trust Company, Lta and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Petrus Trust Company, Lta, based on Form 13F filings with the SEC.

News

Stay updated on Petrus Trust Company, Lta with notifications on news.